<DOC>
	<DOC>NCT00537550</DOC>
	<brief_summary>The present study has been designed to give participating centers the possibility of better understanding the diagnostic and prognostic factors of ALL patients.</brief_summary>
	<brief_title>Adult ALL Treatment at Diagnosis</brief_title>
	<detailed_description />
	<mesh_term>Leukemia, Lymphoid</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<mesh_term>Vincristine</mesh_term>
	<criteria>Diagnosis of acute lymphoblastic leukemia (ALL) Negative myeloperoxidase stain Phenotype T (ALLT) and B(ALLB) Creatinine &gt; 2.5mg/dL after adequate hydratation LVEF &lt;50% Presence of documented infections not responding to antibiotic and/or antifungal therapy Presence of concomitant malignant diseases Absence of any psychological condition that does not allow to intake high doses of cortisone Patients who have received any antineoplastic chemiotherapy for more than 5 days Patients who have received any steroids for more than 10 days</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>ALL</keyword>
	<keyword>Adult</keyword>
</DOC>